Idelalisib-mediated PI3Kδ inhibition for optimized generation of CD19-specific chimeric antigen receptor T cells

被引：0
|
作者：
Stock, Sophia [1 ]
Schubert, Maria-Luisa [1 ]
Hoffmann, Jean-Marc [1 ]
Wang, Lei [1 ]
Gong, Wenjie [1 ]
Neuber, Brigitte [1 ]
Hueckelhoven, Angela [1 ]
Gern, Ulrike [1 ]
Schmitt, Anita [1 ]
Mueller-Tidow, Carsten [1 ,2 ]
Dreger, Peter [1 ,2 ]
Schmitt, Michael [1 ,2 ]
Sellner, Leopold [1 ,2 ]
机构：
[1] Heidelberg Univ Hosp, Dept Internal Med 5, Heidelberg, Germany
[2] German Canc Consortium DKTK, Heidelberg, Germany
来源：
BONE MARROW TRANSPLANTATION | 2018年 / 53卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
O141
引用
收藏
页码：119 / 120
页数：2
相关论文
共 50 条
  • [1] PI3K Inhibition with Idelalisib for Optimized Production of Chimeric Antigen Receptor T Cells
    Stock, Sophia
    Hoffmann, Jean-Marc
    Wang, Lei
    Gong, Wenjie
    Huckelhoven, Angela
    Neuber, Brigitte
    Schubert, Maria-Luisa
    Gern, Ulrike
    Schmitt, Anita
    Mueller-Tidow, Carsten
    Dreger, Peter
    Schmitt, Michael
    Sellner, Leopold
    BLOOD, 2017, 130
  • [2] Idelalisib for optimized CD19-specific chimeric antigen receptor T cells in chronic lymphocytic leukemia patients
    Stock, Sophia
    Uebelhart, Rudolf
    Schubert, Maria-Luisa
    Fan, Fuli
    He, Bailin
    Hoffmann, Jean-Marc
    Wang, Lei
    Wang, Sanmei
    Gong, Wenjie
    Neuber, Brigitte
    Hueckelhoven-Krauss, Angela
    Gern, Ulrike
    Christ, Christiane
    Hexel, Monika
    Schmitt, Anita
    Schmidt, Patrick
    Krauss, Juergen
    Jaeger, Dirk
    Mueller-Tidow, Carsten
    Dreger, Peter
    Schmitt, Michael
    Sellner, Leopold
    INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (05) : 1312 - 1324
  • [3] Optimized production of T cells expressing chimeric antigen receptors through PI3K inhibition with idelalisib
    Stock, S.
    Hoffmann, J. -M.
    Gern, U.
    Wang, L.
    Hueckelhoven, A.
    Neuber, B.
    Schubert, M. -L.
    Schmitt, A.
    Mueller-Tidow, C.
    Dreger, P.
    Schmitt, M.
    Sellner, L.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 212 - 212
  • [4] Humanized CD19-Specific Chimeric Antigen Receptor T Cells for Acute Lymphoblastic Leukemia
    Cao, Jiang
    Cheng, Hai
    Qi, Kunming
    Chen, Wei
    Shi, Ming
    Zheng, Junnian
    Xu, Kailin
    BLOOD, 2019, 134
  • [5] Clinically Adaptable CD19-Specific Chimeric Antigen Receptor
    Diaconu, Iulia
    Savoldo, Barbara
    Dotti, Gianpietro
    MOLECULAR THERAPY, 2014, 22 : S64 - S64
  • [6] Chimeric Antigen Receptor (CAR)-Specific Monoclonal Antibody to Detect CD19-Specific T Cells in Clinical Trials
    Jena, Bipulendu
    Maiti, Sourindra
    Huls, Helen
    Singh, Harjeet
    Lee, Dean A.
    Champlin, Richard E.
    Cooper, Laurence J. N.
    PLOS ONE, 2013, 8 (03):
  • [7] Quantitative single-cell functional characterization of CD19-specific chimeric antigen receptor T cells
    Varadarajan, Navin
    Liadi, Ivan
    Romain, Gabrielle
    Singh, Harjeet
    Cooper, Laurence
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [8] Influence of Retronectin-Mediated T-Cell Activation on Expansion and Phenotype of CD19-Specific Chimeric Antigen Receptor T Cells
    Stock, Sophia
    Hoffmann, Jean-Marc
    Schubert, Maria-Luisa
    Wang, Lei
    Wang, Sanmei
    Gong, Wenjie
    Neuber, Brigitte
    Gern, Ulrike
    Schmitt, Anita
    Mueller-Tidow, Carsten
    Dreger, Peter
    Schmitt, Michael
    Sellner, Leopold
    HUMAN GENE THERAPY, 2018, 29 (10) : 1167 - 1182
  • [9] The impact of the intestinal microbiome on toxicity and efficacy of CD19-specific chimeric antigen receptor (CAR) T cells
    Schubert, M. -L.
    Blumenberg, V.
    Zamir, E.
    Schmidt, S.
    Rohrbach, R.
    Waldhoff, P.
    Bozic, D.
    von Bergwelt, M.
    Mueller-Tidow, C.
    Dreger, P.
    Schmitt, M.
    Subklewe, M.
    Stein-Thoeringer, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 240 - 241
  • [10] Impact of retronectin-mediated T cell activation on CD19-specific chimeric antigen receptor T cells in chronic lymphocytic leukemia patients
    Stock, S.
    Hoffmann, J. -M
    Schubert, M. -L
    Wang, L.
    Wang, S.
    Gong, W.
    Neuber, B.
    Gern, U.
    Schmitt, A.
    Mueller-Tidow, C.
    Dreger, P.
    Schmitt, M.
    Sellner, L.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 86 - 86
12345